Alemtuzumab in refractory Sézary syndrome

Alemtuzumab in refractory Sézary syndrome

Abstract: Sézary syndrome is a primary cutaneous T-cell lymphoma characterized by the triad of erythroderma, lymphadenopathy and circulating atypical cells. The emergence of new molecular targets has enabled the development of drugs such as alemtuzumab, an anti-CD52 monoclonal antibody, which has sh...

Full description

Saved in:
Bibliographic Details
Main Authors: Carmen María Alcántara Reifs (Author), Rafael Salido-Vallejo (Author), Gloria María Garnacho-Saucedo (Author), Sofía De la Corte-Sánchez (Author), Alberto González-Menchen (Author), Antonio Vélez García-Nieto (Author)
Format: Book
Published: Sociedade Brasileira de Dermatologia, 2016-10-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items